Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas
Year: 2016
Type: article
Institutions: Rush University Medical Center, Levine Cancer Institute, Oxford University Hospitals NHS Trust, Medical College of Wisconsin, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, University of Chicago, Institut Català d'Oncologia, Duran i Reynals Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2514962863
